Clinical Study
Autologous Platelet-Rich Plasma Eye Drops for the Treatment of Post-LASIK Chronic Ocular Surface Syndrome
Table 2
Signs and symptoms of post-LASIK ocular surface syndrome before and after monotherapy with autologous platelet-rich plasma eye drops.
| | Number of cases before treatment n (%) | Worsening | No change | Improvement |
| Dry eye symptoms (patients) | 80 (100%) | 0 (0%) | 12 (15%) | 68 (85%) | Fluorescein staining (eyes) | 116 (74.3%) | 2 (1.7%) | 10 (8.6%) | 104 (89.6%) | Conjunctival hyperemia (eyes) | 29 (18.7%) | 0 (0%) | 2 (6.7%) | 27 (93.3%) |
|
|